Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Epidemiological, Molecular, and Clinical Features of Norovirus Infections among Pediatric Patients in Qatar.

Mathew S, Alansari K, K Smatti M, Zaraket H, Al Thani AA, Yassine HM.

Viruses. 2019 Apr 29;11(5). pii: E400. doi: 10.3390/v11050400.

2.

Expression profile of MicroRNA: An Emerging Hallmark of Cancer.

Zaheer U, Faheem M, Qadri I, Begum N, Yassine HM, Al Thani AA, Mathew S.

Curr Pharm Des. 2019;25(6):642-653. doi: 10.2174/1386207322666190325122821.

PMID:
30914015
3.

Mixed Viral-Bacterial Infections and Their Effects on Gut Microbiota and Clinical Illnesses in Children.

Mathew S, Smatti MK, Al Ansari K, Nasrallah GK, Al Thani AA, Yassine HM.

Sci Rep. 2019 Jan 29;9(1):865. doi: 10.1038/s41598-018-37162-w.

4.

The Dual Specificity Role of Transcription Factor FOXO in Type 2-diabetes and Cancer.

Fatima K, Mathew S, Faheem M, Mehmood T, Yassine HM, Al Thani AA, Abdel-Hafiz H, Al Ghamdy K, Qadri I.

Curr Pharm Des. 2018;24(24):2839-2848. doi: 10.2174/1381612824666180911114210.

PMID:
30205794
5.

Computational screening of known broad-spectrum antiviral small organic molecules for potential influenza HA stem inhibitors.

Mathew S, Al Thani AA, Yassine HM.

PLoS One. 2018 Sep 4;13(9):e0203148. doi: 10.1371/journal.pone.0203148. eCollection 2018.

6.

Nanomaterial Induced Immune Responses and Cytotoxicity.

Ali A, Suhail M, Mathew S, Shah MA, Harakeh SM, Ahmad S, Kazmi Z, Alhamdan MA, Chaudhary A, Damanhouri GA, Qadri I.

J Nanosci Nanotechnol. 2016 Jan;16(1):40-57. Review.

PMID:
27398432
7.

Hepatitis C virus and neurological damage.

Mathew S, Faheem M, Ibrahim SM, Iqbal W, Rauff B, Fatima K, Qadri I.

World J Hepatol. 2016 Apr 28;8(12):545-56. doi: 10.4254/wjh.v8.i12.545. Review.

8.

Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma.

Mathew S, Abdel-Hafiz H, Raza A, Fatima K, Qadri I.

World J Hepatol. 2016 Apr 8;8(10):485-98. doi: 10.4254/wjh.v8.i10.485. Review.

9.

In silico inhibition of GABARAP activity using antiepileptic medicinal derived compounds.

Mathew S, Faheem M, Al-Malki AL, Kumosani TA, Qadri I.

Bioinformation. 2015 Apr 30;11(4):189-95. doi: 10.6026/97320630011189. eCollection 2015.

10.

Computational Docking Study of p7 Ion Channel from HCV Genotype 3 and Genotype 4 and Its Interaction with Natural Compounds.

Mathew S, Fatima K, Fatmi MQ, Archunan G, Ilyas M, Begum N, Azhar E, Damanhouri G, Qadri I.

PLoS One. 2015 Jun 1;10(6):e0126510. doi: 10.1371/journal.pone.0126510. eCollection 2015.

11.

Comparison of structural architecture of HCV NS3 genotype 1 versus Pakistani genotype 3a.

Fatima K, Azhar E, Mathew S, Damanhouri G, Qadri I.

Biomed Res Int. 2014;2014:749254. doi: 10.1155/2014/749254. Epub 2014 Oct 21.

12.

Docking studies of Pakistani HCV NS3 helicase: a possible antiviral drug target.

Fatima K, Mathew S, Suhail M, Ali A, Damanhouri G, Azhar E, Qadri I.

PLoS One. 2014 Sep 4;9(9):e106339. doi: 10.1371/journal.pone.0106339. eCollection 2014.

13.

In silico studies of medicinal compounds against hepatitis C capsid protein from north India.

Mathew S, Faheem M, Archunan G, Ilyas M, Begum N, Jahangir S, Qadri I, Qahtani MA, Mathew S.

Bioinform Biol Insights. 2014 Jun 23;8:159-68. doi: 10.4137/BBI.S15211. eCollection 2014.

14.

Biomarkers for virus-induced hepatocellular carcinoma (HCC).

Mathew S, Ali A, Abdel-Hafiz H, Fatima K, Suhail M, Archunan G, Begum N, Jahangir S, Ilyas M, Chaudhary AG, Al Qahtani M, Mohamad Bazarah S, Qadri I.

Infect Genet Evol. 2014 Aug;26:327-39. doi: 10.1016/j.meegid.2014.06.014. Epub 2014 Jun 21. Review.

PMID:
24956436

Supplemental Content

Loading ...
Support Center